Cargando…
Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges
Signal transducers and activators of transcription 3 (STAT-3) is a transcription factor that regulates the gene expression of several target genes. These factors are activated by the binding of cytokines and growth factors with STAT-3 specific receptors on cell membrane. Few years ago, STAT-3 was co...
Autores principales: | Arshad, Sundas, Naveed, Muhammad, Ullia, Mahad, Javed, Khadija, Butt, Ayesha, Khawar, Masooma, Amjad, Fazeeha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198026/ https://www.ncbi.nlm.nih.gov/pubmed/32167126 http://dx.doi.org/10.1590/1678-4685-GMB-2018-0160 |
Ejemplares similares
-
Growth hormone insensitivity with immune dysfunction caused by a STAT5B
mutation in the south of Brazil: evidence for a founder effect
por: Scalco, Renata C., et al.
Publicado: (2017) -
Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer
por: Raja, Sadaf Azad, et al.
Publicado: (2019) -
Engineered scPDL1-DM1 drug conjugate with improved in
vitro analysis to target PD-L1 positive cancer cells and
intracellular trafficking studies in cancer therapy
por: Kalim, Muhammad, et al.
Publicado: (2020) -
Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
por: Mahasneh, Amjad, et al.
Publicado: (2012) -
Plasma GBP2 promoter methylation is associated with
advanced stages in breast cancer
por: Rahvar, Farzaneh, et al.
Publicado: (2020)